P

Inventor

MOSS STEVEN JAMES

GB14 patents
⚠️ This page may combine multiple inventors who share the name “MOSS STEVEN JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MOSS STEVEN JAMES

3 patents
US9119853B2Sep 1, 2015

Sanglifehrin based compounds

MOSS STEVEN JAMES8 citations79
US9139613B2Sep 22, 2015

Macrocyclic compounds and methods for their production

MOSS STEVEN JAMES0 citations48
US9271977B2Mar 1, 2016

Sanglifehrin derivatives and methods for their production

MOSS STEVEN JAMES0 citations36

BIOTICA TECH LTD

2 patents
US7648996B2Jan 19, 2010

39-desmethoxy derivatives of rapamycin

BIOTICA TECH LTD9 citations81
US8008318B2Aug 30, 2011

39-desmethoxy derivatives of rapamycin

BIOTICA TECH LTD6 citations71

Abliva Ab

2 patents
US11565998B2Jan 31, 2023

Succinate prodrug, compositions containing the succinate prodrug and uses thereof

Abliva Ab2 citations63
US12162824B2Dec 10, 2024

Succinate prodrug, compositions containing the succinate prodrug and uses thereof

Abliva Ab0 citations53

BUCK INST FOR RES ON AGING

2 patents
US9382266B2Jul 5, 2016

Rapamycin analogue

BUCK INST FOR RES ON AGING2 citations59
US9605001B2Mar 28, 2017

Production of polyketides and other natural products

BUCK INST FOR RES ON AGING0 citations49

NEUROVIVE PHARMACEUTICAL AB

2 patents
US10857150B2Dec 8, 2020

Use of sanglifehrin macrocyclic analogues as anticancer compounds

NEUROVIVE PHARMACEUTICAL AB0 citations46
US9504728B2Nov 29, 2016

Dosage form

NEUROVIVE PHARMACEUTICAL AB0 citations38

ISOMERASE THERAPEUTICS LTD

2 patents
US9976165B2May 22, 2018

Methods for increasing molecular diversity of polyketides and non-ribosomal proteins

ISOMERASE THERAPEUTICS LTD0 citations46
US9505773B2Nov 29, 2016

Rapamycin analogues and their pharmaceutical use

ISOMERASE THERAPEUTICS LTD0 citations46

GREGORY MATTHEW ALAN

1 patent
US9090657B2Jul 28, 2015

Compound and methods for its production

GREGORY MATTHEW ALAN0 citations47